UK markets closed
NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.74 (-0.93%) GOLD FUTURES
2,424.50 -14.00 (-0.57%) DOW
39,835.64 +28.87 (+0.07%) Bitcoin GBP
54,936.21 +913.39 (+1.69%)
Microbot Medical Inc. (MBOT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 02:57PM EDT. Market open.
| Previous close | 0.9997 |
| Open | 0.9895 |
| Bid | 0.9552 x 100 |
| Ask | 1.0300 x 100 |
| Day's range | 0.9868 - 0.9956 |
| 52-week range | 0.8600 - 3.6600 |
| Volume | |
| Avg. volume | 98,077 |
| Market cap | 14.252M |
| Beta (5Y monthly) | 1.70 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Microbot Medical (MBOT) Files IDE to Start Human Clinical Study
Microbot Medical (MBOT) files an IDE with the FDA, approval of which will enable the company to proceed with its human clinical study in the United States.
- Zacks
Microbot Medical (MBOT) Announces Positive GLP Study Results
Microbot Medical's (MBOT) latest favorable study results are likely to support its IDE submission to the FDA to commence its human clinical study.
- Simply Wall St.
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Deliver On Growth Plans?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
© 2024 Yahoo. All rights reserved.